Barclays lowered the firm’s price target on PSEG (PEG) to $88 from $98 and keeps an Overweight rating on the shares post the Q3 report. The firm sees the share underperformance as a buying opportunity. The share reaction seems overdone relative to PSEG’s long term path of nuclear optimization, the analyst tells investors in a research note.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PEG:
- PSEG Reports Strong Q3 2024 Financial Results
- Charged: Nuclear stocks slide after expansion of Amazon data center blocked
- Talen slides as regulators reject proposal to expand Amazon data center
- Unusually active option classes on open November 4th
- PSEG Reports Strong Q3 Earnings and Future Investments